Germany: GNA Biosolutions raises US$13.5m Series C

Federico Buersgens, co-founder and managing director, GNA Biosolutions

Munich-based molecular diagnostics company GNA Biosolutions has completed US$13.5m Series C funding. New investors including GreyBird Ventures, Occident, and Wachtumsfonds Bayern joined the round as well as existing investors SHS Gesellschaft für Beteiligungsmanagement, Robert Bosch Venture Capital, UVC Partners, Mey Capital Matrix, KfW, and btov Partners. Proceeds from the financing will be used to advance…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »